Medical Oncologist
CION Cancer Clinics
Next-generation sequencing: how reading many genes at once actually works | CION Cancer Clinics
Next-generation sequencing reads many genes at the same time instead of testing one gene after another. That is the single change behind almost every genetic panel offered in cancer care today. This page explains how a sample turns into a list of findings, what coverage and a pipeline actually mean, and why a bigger panel is not automatically a better one for you. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is next-generation sequencing?
- What makes next-generation sequencing different from older methods?
- What happens to your sample between the blood draw and the report?
- The words this report uses, in plain language
- Next-generation sequencing or Sanger sequencing: which does what?
- What this page cannot tell you
- Four things people assume about next-generation sequencing
- Common questions about next-generation sequencing
The short answer
What is next-generation sequencing?
Next-generation sequencing reads many genes at the same time instead of one gene at a time. That single change is why cancer genetic testing moved from slow, single-gene tests to a panel that checks a whole group of genes in one sitting. Most inherited cancer testing done today uses this method somewhere in the process.
Why reading many genes together matters
Older methods needed a fair guess about which gene to check before testing began. Next-generation sequencing removes most of that guessing. A laboratory can read a panel built around a cancer type, or occasionally a much larger set of genes, and let the result show which one, if any, carries the fault.
How it changed who gets tested
Because many genes are read together at a similar cost to reading one, panels have become the normal starting point rather than a last resort. Families who once needed several separate single-gene tests, one after another, can now often be answered from a single sample.
Reading a gene is not the same as understanding every letter it contains. The next step, working out what a difference means, is still done by people, not machines.What actually changed
What makes next-generation sequencing different from older methods?
The name suggests one invention. It is really a change in scale, and that change has knock-on effects worth knowing about.
Many genes, one run
Instead of testing genes one after another, a laboratory reads thousands of short fragments from many genes at once, then reassembles them by computer into a full picture of each gene.
Each letter is read more than once
Every position is read repeatedly rather than a single time, and the repeated reads are compared to each other. That repetition is what lets a laboratory trust a result rather than a single reading, which could contain an error.
A computer does the assembly
The raw output is millions of short, jumbled fragments. Software lines them up against a reference map of the human genome to work out where each fragment belongs before a scientist ever looks at the result.
Which is why you may hear about
- Coverage, meaning how many times each spot was read
- Pipelines, the software steps between raw data and a report
- Confirmation testing for anything the pipeline flags
It still needs a human decision
The machine produces letters, not verdicts. A geneticist decides whether a difference from the reference map matters, using databases and published evidence, before it is written into your report.
Not sure whether this applies to you?
Ask an oncologistFrom sample to result
What happens to your sample between the blood draw and the report?
Preparing the sample
DNA is extracted from your blood or saliva sample and chopped into short, manageable fragments in the laboratory.
Selecting the target genes
Only the genes on your requested panel, or in some cases a much larger set, are pulled out and prepared for reading.
The sequencing run
The machine reads all the fragments at once, producing a huge volume of short, overlapping reads rather than one long one.
Assembly and analysis
Software reassembles the fragments against the reference map, flags every difference, and a geneticist reviews the flagged spots before your report is written.
On your report
The words this report uses, in plain language
- Panel
- A chosen list of genes read together, usually built around a family of related cancers.
- Coverage
- How many separate times a given spot in the DNA was read. Low coverage anywhere can mean that spot needs a repeat test.
- Reference genome
- The standard human sequence every result is compared against to find differences.
- Read
- One short fragment of sequence produced by the machine, before it is reassembled into a full gene.
- Pipeline
- The chain of software steps that turns raw machine output into a list of findings a geneticist can review.
- Variant call
- A place where your sequence differs from the reference genome, flagged for a human to assess.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Next-generation sequencing or Sanger sequencing: which does what?
Next-generation sequencing
Sanger sequencing
Reads many genes together in one run
Reads one small, chosen stretch of one gene
The usual first, searching test today
Usually the last, confirming step
Can surface a finding nobody expected
Only reads exactly where it is aimed
Needs a computer pipeline to assemble results
Produces a directly readable chart
Being straight with you
What this page cannot tell you
It cannot tell you what your own result means. Two people can carry a different spelling difference in the same gene and be told very different things, because not every difference is harmful. That judgement belongs to a genetic counsellor or clinical geneticist, not to a general description of the technology.
It cannot promise a clean answer
Reading more genes at once also means finding more spelling differences whose meaning is not yet clear. A larger panel is not automatically a better choice for you, because a wider search can bring back more uncertain findings alongside the useful ones.
Who this does not apply to
If your family history does not suggest an inherited pattern, a broad panel is unlikely to be the recommended starting point. A counsellor weighs your family tree against the size of panel that actually fits your situation, rather than defaulting to the largest one available.
If you have been offered a panel and are unsure why that particular size was chosen, ask. It is a reasonable question and a good counsellor will have an answer.Commonly believed
Four things people assume about next-generation sequencing
"Bigger panels always give a better answer."
A bigger panel searches more genes, but it also turns up more spelling differences of uncertain meaning. The right size of panel depends on your family history, not on choosing the largest one on offer.
"The computer decides what the result means."
Software only reassembles the raw data and flags differences from the reference map. Deciding whether a flagged difference actually matters is done by trained people, using published evidence.
"If it is not found on a panel, it does not
exist."
A panel only reads the genes chosen for it. A fault sitting in a gene outside that panel will not be found, which is why the choice of panel is discussed with a counsellor rather than assumed.
"This test also tells doctors about the tumour
itself."
This kind of testing, done on blood or saliva, looks at the genes you were born with. Testing the tumour tissue itself for changes that happened only inside the cancer is a separate test, used for treatment planning.
Questions we are asked
Common questions about next-generation sequencing
Is next-generation sequencing the same as a DNA test?
It is one method of doing a DNA test, and the one most cancer genetics panels use today. "DNA test" describes the goal; next-generation sequencing describes the technology behind it.
Does a bigger panel mean a more accurate result?
Not necessarily. A bigger panel searches more genes, which can mean more findings of uncertain meaning rather than a clearer answer. Accuracy comes from careful laboratory work, not panel size alone.
How long does next-generation sequencing take?
The sequencing run itself is only part of the timeline. Sample preparation, analysis and clinical review around it usually take longer than the actual reading, so turnaround varies by laboratory.
Can this test tell me about a tumour that has already
been removed?
Blood or saliva based next-generation sequencing looks at the genes you were born with, not the tumour itself. Testing tumour tissue for changes specific to that cancer is a different test, usually arranged by the treating oncologist.
What happens if the pipeline flags something unusual?
Anything flagged is reviewed by a geneticist and, in most laboratories, confirmed by an independent method before it appears on your report. A flag in the raw data is not the same as a confirmed finding.
Why did my laboratory recommend a small panel instead of
the largest one available?
Because your family history pointed to a particular group of genes. Choosing a panel that matches your situation, rather than the widest one, usually gives a clearer result with fewer uncertain findings.
Does next-generation sequencing replace the need for a
genetic counsellor?
No. The technology produces the raw findings. A counsellor is still the person who chooses the right panel, explains the result and decides what it means for you and your family.
Where do I start if I want this kind of test?
Speak to a genetic counsellor or your oncologist about your family history first. They will recommend the panel that fits your situation rather than the largest one on the market.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- MedlinePlus Genetics — What is next-generation sequencing?
- GeneReviews (NCBI) — Genetic Testing: Overview
- NCCN — Genetic/Familial High-Risk Assessment Guidelines
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Sanger sequencing and where it is still usedThe confirming step that usually follows a panel findingMultigene panel testing explainedHow a panel is actually built and chosenHow many genes should a panel include?Why bigger is not automatically betterHow to read a germline genetic test reportMaking sense of what the panel actually found
Talk to us
Wondering which panel fits your family history?
Tell us who in your family has been affected and we will help you understand what size of panel actually makes sense. One helpline serves every CION centre.